A Timely Confluence: The Backstory of Moderna’s COVID-19 Vaccine

Members were invited to join us for this unique opportunity to hear from Academy member Melissa Moore, Chief Scientific Officer at Moderna Therapeutics, as she shared the story of developing the COVID-19 vaccine in this unrecorded, closed-door discussion.